Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ObsEva to discontinue nolasiban IVF program after phase III trial misses primary endpoint

Nov. 7, 2019

Bristol-Myers Squibb presents new MGAT2 inhibitors

Nov. 7, 2019

Early clinical data presented for AGIL-AADC gene therapy in children with AADC deficiency

Nov. 7, 2019

Low-coverage genome sequencing gives answers in infertility

Nov. 7, 2019

Investigators design mouse model of dwarfism with PCSK1 mutation

Nov. 6, 2019

Promising preclinical results presented for DTX-701, a gene therapy for Wilson disease

Nov. 5, 2019

Neuropore Therapies divulges PIK3C3 inhibitors

Nov. 4, 2019

BCX-9250 enters phase I development for treatment of fibrodysplasia ossificans progressiva

Nov. 4, 2019

Bayer Pharma describes new kallikrein B inhibitors

Oct. 31, 2019

Japan Tobacco describes new SLC5A1 inhibitors

Oct. 25, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...